(Q39293475)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28485723%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

review article

1 reference

title

Developing gene and cell therapies for rare diseases: an opportunity for synergy between academia and industry (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28485723%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28485723%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

author name string

F Mavilio

series ordinal

1

1 reference

10 September 2017

25 May 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28485723%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28485723%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28485723%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28485723%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

page(s)

590-592

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28485723%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/gt.2017.36

20 March 2020

exact match

0 references

cites work

Gene therapy. Italians first to use stem cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2017.36

Gene therapy in peripheral blood lymphocytes and bone marrow for ADA- immunodeficient patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2017.36

T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2017.36

Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2017.36

Immune reconstitution in ADA-SCID after PBL gene therapy and discontinuation of enzyme replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2017.36

Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2017.36

Gene therapy for immunodeficiency due to adenosine deaminase deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2017.36

Mechanisms of retroviral integration and mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2017.36

Gene therapy returns to centre stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2017.36

Orphan drug development: an economically viable strategy for biopharma R&D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2017.36

The Principles of Engineering Immune Cells to Treat Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2017.36

Lessons learned from the clinical development and market authorization of Glybera.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2017.36

Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2017.36

Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2017.36

Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2017.36

Gene therapy prolongs survival and restores function in murine and canine models of myotubular myopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2017.36

Promising gene therapies pose million-dollar conundrum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2017.36

Limbal Stem-Cell Therapy and Long-Term Corneal Regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2017.36

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/GT.2017.36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28485723%20AND%20SRC:MED&resulttype=core&format=json

release_5fmkfkai3nfvhk44vscm62aqme

20 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5fmkfkai3nfvhk44vscm62aqme

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference